Zobrazeno 1 - 1
of 1
pro vyhledávání: '"GITMO GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO"'
Autor:
ZAJA, Francesco, BACIGALUPO A, PATRIARCA, Francesca, STANZANI M, VAN LINT M. T, FILÌ C, SCIME R, MILONE G, FALDA M, VENER C, LASZLO D, ALESSANDRINO P. E, NARNI F, SICA S, OLIVIERI A, SPEROTTO A, BOSI A, BONIFAZI F, FANIN, Renato, GITMO GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO
The anti-CD20 chimaeric monoclonal antibody Rituximab has recently been shown to induce significant clinical response in a proportion of patients with refractory chronic graft-versus-host disease (cGVHD). We now report 38 patients, median age 48 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c59bf8d2b72c7c3669b15fa3cfde134a
http://hdl.handle.net/11368/2953475
http://hdl.handle.net/11368/2953475
